SMS and Android application based Intervention in Diabetes

SMS and Android application based Intervention in Diabetes: A Community-based Intervention study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081367

Enrollment

280

Registered

2025-02-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: SMS and Android application based Intervention: It is a crossover intervention trial. By time randomization at the PHC level, the PHC-I center participants will receive SMS during the f

in Addition to SMS, we will send follow-up notifications through the android application with feedback questions. The trial involves 2 visits after screening (6 and 12 months). Control Intervention1:

in Addition to SMS, we will send follow-up notifications through the android application with feedback questions. The trial involves 2 visits after screening (6 and 12 months).

Eligibility

Inclusion criteria

Inclusion criteria: Type-two diabetes Has a personal Android mobile phone Knows how to retrieve and read SMS on the mobile phone Available for the study duration and those who gave informed consent to participate.

Exclusion criteria

Exclusion criteria: Patients with clinical conditions that might interfere with the study such as pregnancy, severe mental illness affecting cognition, inability to read SMS properly, other serious illness or co-morbidities that may decrease or prevent compliance to SMS instructions.

Design outcomes

Primary

Measure	Time frame
The primary study outcome is the difference between the PHC one and the PHC second centres for the change of HbA1c level between M0 and M6 months, to assess the impact of the SMS programme on glycaemic controlTimepoint: 12 months	—

Secondary

Measure	Time frame
To assess the effect of the intervention on patients with type 2 diabetes in terms of diabetes-related knowledge using a predesigned structured interviewing questionnaire The evaluation of HbA1c between M7 & M12 in the PHC-I centre in order to check whether there was a residual effect of SMS on glycaemic control and The evaluation of HbA1c between M7 & M12 in the PHC-II centre in order to confirm the benefit, if any, of the SMS programme on glycaemic control.HbA1c will be measured locally in each PHC centre, & the same HbA1c assay will be used in both centres during the entire study period. Timepoint: 12 months	—

Measure

Time frame

To assess the effect of the intervention on patients with type 2 diabetes in terms of diabetes-related knowledge using a predesigned structured interviewing questionnaire The evaluation of HbA1c between M7 & M12 in the PHC-I centre in order to check whether there was a residual effect of SMS on glycaemic control and The evaluation of HbA1c between M7 & M12 in the PHC-II centre in order to confirm the benefit, if any, of the SMS programme on glycaemic control.HbA1c will be measured locally in each PHC centre, & the same HbA1c assay will be used in both centres during the entire study period. Timepoint: 12 months

—

Countries

India

Contacts

Public ContactDr Ramesh Kumar Huda

ICMR-National Institute for Implementation Research on Non Communicable Diseases

rameshk.h@icmr.gov.in09602755600

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026